R&D AMR research and Matoke Pharma: the pharmaphorum podcast Re-engineered honey has proved to be a novel and successful development for Matoke Pharma, as well as a crucial step on the UK biotech company’s plans to target antimicrobial resistance (AM
Partner Content Partner Content Discuss recent developments in bacterial immunotherapy at Su... SMi reports: The 21st annual Superbugs & Superdrugs conference will be returning to London in just two weeks’ time.
Partner Content Partner Content Combating Antifungal Resistance to be discussed at Superbugs... Antifungal Resistance at Superbugs & Superdrugs 2019
Partner Content Partner Content WHO's Senior Advisor to speak at 21st Annual Superbugs &... WHO to speak at 21st Superbugs & Superdrugs 2019
Partner Content Partner Content Challenges including Funding and Lack of Incentives Hinder A... Explore Challenges in Antibiotic Research
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
